Correlation Between XORTX Therapeutics and Marvel Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both XORTX Therapeutics and Marvel Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XORTX Therapeutics and Marvel Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XORTX Therapeutics and Marvel Biosciences Corp, you can compare the effects of market volatilities on XORTX Therapeutics and Marvel Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XORTX Therapeutics with a short position of Marvel Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of XORTX Therapeutics and Marvel Biosciences.

Diversification Opportunities for XORTX Therapeutics and Marvel Biosciences

-0.43
  Correlation Coefficient

Very good diversification

The 3 months correlation between XORTX and Marvel is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding XORTX Therapeutics and Marvel Biosciences Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marvel Biosciences Corp and XORTX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XORTX Therapeutics are associated (or correlated) with Marvel Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marvel Biosciences Corp has no effect on the direction of XORTX Therapeutics i.e., XORTX Therapeutics and Marvel Biosciences go up and down completely randomly.

Pair Corralation between XORTX Therapeutics and Marvel Biosciences

Assuming the 90 days trading horizon XORTX Therapeutics is expected to under-perform the Marvel Biosciences. In addition to that, XORTX Therapeutics is 1.09 times more volatile than Marvel Biosciences Corp. It trades about -0.01 of its total potential returns per unit of risk. Marvel Biosciences Corp is currently generating about 0.14 per unit of volatility. If you would invest  14.00  in Marvel Biosciences Corp on September 2, 2024 and sell it today you would earn a total of  2.00  from holding Marvel Biosciences Corp or generate 14.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

XORTX Therapeutics  vs.  Marvel Biosciences Corp

 Performance 
       Timeline  
XORTX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Marvel Biosciences Corp 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Marvel Biosciences Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Marvel Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

XORTX Therapeutics and Marvel Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with XORTX Therapeutics and Marvel Biosciences

The main advantage of trading using opposite XORTX Therapeutics and Marvel Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XORTX Therapeutics position performs unexpectedly, Marvel Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marvel Biosciences will offset losses from the drop in Marvel Biosciences' long position.
The idea behind XORTX Therapeutics and Marvel Biosciences Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance